trending Market Intelligence /marketintelligence/en/news-insights/trending/l_NYIPKccxc5n8ZOF4xsxA2 content esgSubNav
In This List

Lupin receives FDA approval to market generic antidepressant drug

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Lupin receives FDA approval to market generic antidepressant drug

India-based Lupin Ltd. received U.S. FDA approval to market its Paroxetin extended release tablets, a generic of Apotex Technologies Inc.'s Paxil CR tablets.

The drug is indicated for the treatment of major depressive disorder, panic disorder, social anxiety disorder and premenstrual dysphoric disorder.

Lupin will begin promoting the product soon.